IceCure Medical: Funding, Investors & Team (Oct 2026)
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for women’s health and interventional oncology. Founded in 2006 to advance the treatment of cancerous tumors, IceCure’s core technology is based on cryoablation. Its proprietary third-generation technology uses freezing temperatures (liquid nitrogen) to effectively destroy tumors safely, quickly, and painlessly, without the need for surgery. Commercially available in the U.S.A., Europe, Hong-Kong, Thailand, Singapore and South- Central America, its flagship system, ProSense™, uses ultrasound imaging to guide a small probe (thin hollow needle) into the tumor. The easy-to-use ProSense™ cryoablation procedure enables full physician control and can be performed in less than 30 minutes in the comfort of a doctor’s office. As a proven solution for the treatment of fibroadenomas (benign breast tumors), the ProSense system is also indicated for use in the fields of general surgery, oncology, gynecology and urology.
IceCure Medical has raised $5.5M across 1 funding round on record, the most recent an undisclosed round of $5.5M announced in Jun 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IceCure Medical Company Profile and Key Stats
Latest funding round on record: Jun 2026.
IceCure Medical Funding Rounds
IceCure Medical Founders and Leadership Team
No contact details are on record for this team yet.
IceCure Medical Funding Compared to Other Biotechnology Startups
IceCure Medical's latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IceCure Medical in Biotechnology and Caesarea
Companies Similar to IceCure Medical
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
NeuroSense Therapeutics Ltd., is a clinical-stage biotechnology company, dedicated to the discovery and…
IceCure Medical Funding FAQs
What does IceCure Medical do?
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for women’s health and interventional oncology. Founded in 2006 to advance the treatment of cancerous tumors, IceCure’s core technology is based on cryoablation. Its proprietary third-generation technology uses freezing temperatures (liquid nitrogen) to effectively destroy tumors safely, quickly, and painlessly, without the need for surgery. Commercially available in the U.S.A., Europe, Hong-Kong, Thailand, Singapore and South- Central America, its flagship system, ProSense™, uses ultrasound imaging to guide a small probe (thin hollow needle) into the tumor. The easy-to-use ProSense™ cryoablation procedure enables full physician control and can be performed in less than 30 minutes in the comfort of a doctor’s office. As a proven solution for the treatment of fibroadenomas (benign breast tumors), the ProSense system is also indicated for use in the fields of general surgery, oncology, gynecology and urology.
How much funding has IceCure Medical raised?
IceCure Medical has raised $5.5M across 1 round on record. The most recent is an undisclosed round of $5.5M announced in Jun 2026.
When did IceCure Medical last raise funding?
IceCure Medical's most recent funding round on record is an undisclosed round of $5.5M, announced in Jun 2026.
Who founded IceCure Medical?
FundedIQ lists Eyal Shamir (Founder) at IceCure Medical.
Where is IceCure Medical headquartered?
IceCure Medical is based in Caesarea, Hefa, Israel.
How many employees does IceCure Medical have?
IceCure Medical is in the 51-100 employee band.
How does IceCure Medical's funding compare to other Biotechnology startups?
IceCure Medical's latest round of $5.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's IceCure Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IceCure Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.